la inmunoterapia parece no ser la respuesta inicial para el tratamiento del carcinoma urotelial metastáasico avanzado, al menos no sobre quimioterapia en la primera línea de tratamiento. #cancer #CancerResearch https://t.co/dWn8pQSbYQ
Aktueller #CochraneReview: "Immuntherapie im Vergleich zu Chemotherapie zur Behandlung von inoperablem oder metastasiertem Blasenkrebs" Mehr: https://t.co/tb4f4DtWiw
RT @CochraneLibrary: #Immunotherapy vs #chemotherapy for treating inoperable or metastatic #bladdercancer 🔎 📚 Cochrane authors looked at…
Cochrane Review: Immunotherapy for advanced or metastatic urothelial carcinoma https://t.co/2XYQCFnqs6 #Cancer
RT @CochraneLibrary: #Immunotherapy vs #chemotherapy for treating inoperable or metastatic #bladdercancer 🔎 📚 Cochrane authors looked at…
#Immunotherapy vs #chemotherapy for treating inoperable or metastatic #bladdercancer 🔎 📚 Cochrane authors looked at the evidence from 5 randomized trials in this #SystematicReview https://t.co/vjavYuYXT6